Databases as policy instruments. about extending networks as evidence-based policy

BMC Health Services Research

Volumn 7, Issue , 2007, Pages

  De Bont, Antoinette ^a   Stoevelaar, Herman ^a   Bal, Roland ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GROWTH HORMONE; PACLITAXEL; HUMAN GROWTH HORMONE;

ARTICLE; CLINICAL PRACTICE; COOPERATION; COST CONTROL; DATA BASE; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; INFORMATION PROCESSING; INFORMATION SERVICE; INFORMATION STORAGE; INTERVIEW; NETHERLANDS; PHYSICIAN; PRESCRIPTION; QUALITY CONTROL; REIMBURSEMENT; DRUG THERAPY; FACTUAL DATABASE; HEALTH SERVICES RESEARCH; INSTRUMENTATION; MANAGEMENT; PRACTICE GUIDELINE; STANDARD; TELECOMMUNICATION; UTILIZATION REVIEW;

ANTI-RETROVIRAL AGENTS; COOPERATIVE BEHAVIOR; DATABASES, FACTUAL; DRUG THERAPY; EVIDENCE-BASED MEDICINE; FOCUS GROUPS; HEALTH POLICY; HUMAN GROWTH HORMONE; HUMANS; INTERVIEWS AS TOPIC; NETHERLANDS; ORGANIZATIONAL CASE STUDIES; PACLITAXEL; POLICY MAKING; PRACTICE GUIDELINES AS TOPIC; TELECOMMUNICATIONS;

EID: 38149083392     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-7-200     Document Type: Article

References (29)

1. Cross sectional survey of multicentre clinical databases in the United Kingdom. N Black M Barker M Payne, British Medical Journal 2004 328 1478 15205292 10.1136/bmj.328.7454.1478
2. Using evidence to inform health policy: case study. S Macintyre I Chalmers R Horton R Smith, British Medical Journal 2001 322 222 225 11159625 10.1136/bmj.322.7280.222
3. Evidence based policy or policy based evidence? MG Marmot, BMJ 2004 328 7445 906 907 15087324 10.1136/bmj.328.7445.906
4. Evidence based policy: don't be timid. K Walshe, British Medical Journal 2001 323 1187 11711418 10.1136/bmj.323.7322.1187
5. Evidence-based Management: From theory to practice in health care. K Walshe T Rundall, Milbank Quarterly 2001 79 3 429 457 10.1111/1468-0009.00214 11565163
6. Why we need observational studies to evaluate the effectiveness of health care. N Black, British Medical Journal 1996 312 1215 1218 8634569
7. Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C. A Padkin K Rowan N Black, BMJ 2001 323 7318 923 926 11668142 10.1136/bmj.323.7318.923
8. Policy analysis in aninformation-rich environment. L Roos V Menec R Currie, Social Science & Medicine 2004 2231 2241 10.1016/j.socscimed.2003. 08.008
9. Evidence based policy: proceed with care. Commentary: research must be taken seriously. N Black A Donald, British Medical Journal 2001 323 275 279 11485961 10.1136/bmj.323.7307.275
10. Performance Information for Democracy. The missing link? C Pollitt, Evaluation 2006 12 1 38 55 10.1177/1356389006064191
11. Directory of clinical databases: improving and promoting their use. Quality and Safety in Health Care 2003. N Black M Payne, Quality and Safety in Health Care 2003 12 348 352 10.1136/qhc.12.5.348
12. Cultural governance: governing self-reflexive modernity. HK Bang, Public Administration 2004 82 157-190
13. A Sociology of Technology Governance for the Information Age: The Case of Pharmaceuticals, Consumer Advertising and the Internet. N Fox K Ward A O'Rourke, Sociology 2006 40 315 334 10.1177/0038038506062035
14. Information technologies and global politics. J Rosenau J Singh (eds), Albany: State University Press 2002
15. Of forms, containers, and the electronic medical record: Some tools for a sociology of the formal. M Berg, Science, technology, & human values 1997 4 1 403 431 10.1177/016224399702200401
16. Accumulating and coordinating: occasions for information technologies in medical work. M Berg, Computer Supported Cooperative work 1999 4 431 452
17. KABINETSSTANDPUNT OP RAPPORTEN GENEESMIDDELENBELEID. VWS, The Hague: VWS 2000
18. Conditional reimbursement within the Dutch drug policy. M Niezen A De Bont E Stolk L Niessen H Stoevelaar, Health Policy 2007 84 1 39 50 10.1016/j.healthpol.2006.11.005 17207886
19. Prioritisation by physicians in the Netherlands - the growth hormone example in drug reimbursement decisions. A Bont G de Zandwijken E Stolk L Niessen, Health Policy 2007 80 1 369 377 16684580
20. NICE: Faster Guidance to Modern Treatments? Analysis of Guidance of Technologies. J Raftery, British Medical Journal 2001 232 1300 1303 10.1136/bmj.323.7324.1300
21. Drug Reimbursement in Finland - a Case of Explicit Prioritising in Special Categories. L Vuorenski H Toiviainen E Hemminki, Health Policy 2003 66 169 177 10.1016/S0168-8510(03)00042-3 14585516
22. Geneesmiddel Taxol. Borst, The Hague: Parlement 2000
23. Evaluatie Landelijk Onderzoek Taxoiden. CVZ, Amstelveen: CVZ 2001
24. Some elements of a sociology of translation: domestrication of the scallops and the fishermen of St. Brieuc Bay. M Callon, Power, Action and belief - a new sociology of knowledge? London: Routhledge, Law JaPK, 1986 196 233
25. Rapport doelmatig gebruik groeihormoon. Ziekenfondsraad, Amstelveen: Ziekenfondsraad 1996
26. Monitoring of Human Immunodeficiency Virus type 1 (HIV01) Infection in the Netherlands. FD Wolf J Lange P Bossuyt M Dijkgraaf D Burger P Nieuwker P Reiss, Amsterdam 2001
27. Evalution, policy learning and evidence based policy making. I Sanderson, Public Administration 2002 80 1 1 22 10.1111/1467-9299.00292
28. Science on Stage: expert advice as a public drama. S Hilgartner, Stanford: Stanford University Press 2000
29. States of knowledge: the co-production of science and social order. S Jasanoff, London: Routhledge 2004